;

Search Results:

Showing of 50

CLINICAL TRIAL14690

Total Cancer Care Protocol: A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer

Cancer Type: Cancer Control

View Trial Details

CLINICAL TRIAL16962

A Phase I Trial of Dose Escalation of Metformin in Combination with Vincristine, Irinotecan, and Temozolomide in Children with Relapsed or Refractory Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18374

A Phase II Trial Evaluating the use of a Histone Deacetylase Inhibitor Panobinostat for Graft Versus Host Disease (GVHD) Prevention

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18613

Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults

Cancer Type: Sarcoma

View Trial Details

CLINICAL TRIAL18525

Community Research Registry

Cancer Type: Healthy Subjects

View Trial Details

CLINICAL TRIAL18327

Improving Adolescent and Young Adult Cancer Survivorship

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18906

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an anti-TIM-3 Monoclonal Antibody, in Patients with Advanced Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL17690

A Phase I Trial of Single Agent Trametinib (GSK1120212) in Advanced Cancer Patients with Hepatic Dysfunction

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18786

A Phase 2, Randomized, Multi-institutional Study of Nivolumab and Ipilimumab versus Nivolumab, Ipilimumab and Stereotactic Body Radiation Therapy for Metastatic Merkel Cell Carcinoma

Cancer Type: Cutaneous

View Trial Details

CLINICAL TRIAL18537

A Phase 1b/2 Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of a Novel Transforming Growth Factor-B Receptor I Kinase Inhibitor (Galunisertib) Administered in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumours (Phase 1b) and in Recurrent or Refractory Non-Small Cell Lung Cancer or Hepatocellular Carcinoma (Phase 2)

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18537

A Phase 1b/2 Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of a Novel Transforming Growth Factor-B Receptor I Kinase Inhibitor (Galunisertib) Administered in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumours (Phase 1b) and in Recurrent or Refractory Non-Small Cell Lung Cancer or Hepatocellular Carcinoma (Phase 2)

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18940

The Complexity of Family-Centered Care: Identifying Support and Decision-Making Needs and Expectations of Young Adult Cancer Patients, Partner and Parent Caregivers

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18561

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE 158)

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18938

A Phase 1 Study Evaluating the Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*0401 Positive Subjects with Advanced Cancers

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18420

Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population

Cancer Type: Sarcoma

View Trial Details

CLINICAL TRIAL19131

Contribution of Sleep Disruption and Physical Inactivity to Fatigue In Survivors of Allogeneic Hematopoietic Cell Transplant

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18626

Carfilzomib for Treatment of Chronic Graft vs. Host Disease

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL19068

Refinement of an Assessment Tool to Identify Cancer Survivorship Needs

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18671

Facilitating Smoking Cessation with Reduced Nicotine Cigarettes

Cancer Type: Healthy Subjects

View Trial Details